S
We are long-term investors in engineering biology to treat - or better, cure - human disease.
Investing at the crossroads of biotechnology, nutrition and health.
We are an early-stage investor in one of the most dynamic and essential fields of current human endeavor.
We bring robust investor muscle to early-stage ventures.